Skip to content
Eastwood Companies
  • About
  • Products
    • Blood Glucose Health
    • Blood Pressure Health
    • Brain Health
    • Obesity/Detox
    • Health Improvement/Beauty
    • Media
  • Program
  • Science
  • News & Updates
    • Media Reports
    • Newsletter
    • Public Health News
  • Interviews
  • EPC
  • Contact
  • Privacy Policy
  • Events
    • Singapore 10,000 Steps Challenge
    • Vancouver 10,000 Steps Challenge
  • Sign In / Register
    Sign In / Register

Researchers develop Alzheimer’s vaccine

Public Health News

Researchers in Sweden have developed a vaccine that helps improve the symptoms of people with mild to moderate Alzheimer’s disease.

 

The study, published in Lancet Neurology, says this is a breakthrough in the search for a cure to the dementia disease.

 

The researchers noted the vaccine focuses on the amyloid precursor protein, which resides in the outer membrane of nerve cells and that, instead of being broken down, can form a harmful substance called beta-amyloid, which accumulates as plaques and kills brain cells.

 

In the second clinical trial in humans, the researchers found 80% of patients developed their own protective antibodies against beta-amyloid without suffering any side-effects over the three years of the study.

 

The researchers now want to use the vaccine, called CAD106, in a larger clinical trial to see if they get the same results.

 

Original Post from: http://www.torontosun.com/2012/06/07/researchers-develop-alzheimers-vaccine

Original Post from: http://www.torontosun.com/2012/06/07/researchers-develop-alzheimers-vaccine

Post navigation

← Previous Post
Next Post →
Copyright © 2023 Eastwood Companies
en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianpt Portugueseru Russianes Spanish